Concepedia

David C. Hohn

DC

20

Publications

1.7K

Citations

17

H-Index

1974

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

University of California, San Francisco

Cancer Research Institute

David C. Hohn is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and hepatology.

Top concepts

MedicineOncologySurgeryHepatologyHealthCancer ResearchLiver PhysiologyHematologyImmunologyRadiation Oncology

Publications per year

1974–1996

20

Publications

20

A randomized trial of continuous intravenous versus hepatic intraarterial floxuridine in patients with colorectal cancer metastatic to the liver: the Northern California Oncology Group trial.

David C. Hohn, Robert Stagg, Michael Friedman et al. · Journal of Clinical Oncology · 1989 · 453 citations

Colorectal Cancer Metastatic, Hepatology, Gastrointestinal Oncology +14

NADPH oxidase deficiency in X-linked chronic granulomatous disease.

David C. Hohn, Robert I. Lehrer · Journal of Clinical Investigation · 1975 · 250 citations · Full text

Inflammation, Autoimmune Disease, Normal Donors +14

Effect of O2 tension on microbicidal function of leukocytes in wounds and in vitro.

David C. Hohn, R D MacKay, Betty J. Halliday et al. · PubMed · 1976 · 199 citations

Mechanobiology, Inflammation, O2 Tension +11

Chemoembolization for hepatocellular carcinoma.

Alan P. Venook, Robert Stagg, B.J. Lewis et al. · Journal of Clinical Oncology · 1990 · 170 citations

Hepatic Disorders, Hepatology, Medicine +15

Alternating Hepatic Intra-Arterial Floxuridine and Fluorouracil: A Less Toxic Regimen for Treatment of Liver Metastases From Colorectal Cancer

Robert Stagg, Alan P. Venook, Judy L. Chase et al. · JNCI Journal of the National Cancer Institute · 1991 · 98 citations

Rows per page

1–5 of 20